What Is BPC-157? A Research Overview
BPC-157 (Body Protection Compound 157) is one of the most studied peptides in preclinical research. Here's what the literature says about its mechanisms, applications, and protocols.
BPC-157 — Body Protection Compound 157 — is a synthetic pentadecapeptide derived from a partial sequence of body protection compound found in human gastric juice. It has been the subject of extensive preclinical research since the 1990s, with studies investigating its effects on tissue repair, inflammation, gut health, and neurological function.
What the Research Shows
The body of preclinical literature on BPC-157 is substantial. Studies conducted primarily in rodent models have examined the compound across a range of tissue types and injury models. Key findings in published research include:
Tendon and Ligament Repair — Multiple studies have reported accelerated healing of Achilles tendon, patellar tendon, and ligament injuries in rat models. The compound appears to influence collagen synthesis and organization in connective tissue.
Gut Mucosal Healing — Derived from gastric juice, BPC-157 has a natural affinity for gastrointestinal tissue. Research has demonstrated protective effects on the stomach and intestinal lining in models of NSAID-induced damage, inflammatory bowel conditions, and surgical anastomosis healing.
Anti-Inflammatory Properties — BPC-157 has shown consistent anti-inflammatory activity across multiple research contexts, potentially through modulation of prostaglandin and nitric oxide pathways.
Neurological Research — More recently, preclinical studies have investigated BPC-157's neuroprotective potential, including models of traumatic brain injury and dopaminergic system modulation.
Mechanism of Action
The precise molecular mechanisms behind BPC-157's effects are still being characterized in the literature. Current research suggests involvement in:
- Growth hormone receptor signaling pathways
- VEGF (vascular endothelial growth factor) upregulation — promoting angiogenesis and tissue vascularization
- Nitric oxide system modulation
- Influence on the gut-brain axis
Research Protocols in the Literature
Published studies have used varying administration routes including subcutaneous injection, oral gavage (in gut-focused research), and intraperitoneal injection. Doses in animal models typically range from 10–100mcg/kg, administered daily or several times per week depending on the protocol.
Researchers frequently pair BPC-157 with TB-500 (Thymosin Beta-4 fragment) in recovery-focused protocols, as the two compounds appear to work through complementary mechanisms — BPC-157 targeting local tissue repair and TB-500 supporting broader cellular migration and inflammation resolution.
Purity and Storage
For research applications, compound purity is critical to reproducible results. Apex Life Science Labs supplies BPC-157 at ≥99.9% purity, verified by HPLC analysis. COAs are available on request.
Lyophilized BPC-157 should be stored at 2–8°C protected from light. Once reconstituted with bacteriostatic water, use within 28 days and maintain refrigeration.
This article is for informational and research purposes only. BPC-157 is not approved for human or veterinary therapeutic use. All research should be conducted in compliance with applicable regulations in your jurisdiction.